Day: November 18, 2024

Nine-Month Revenue of Nearly $90M, with Off-Road Vehicles as the Core Revenue Driver Strong Financial Position with $260M in Liquidity New Leadership to Drive Technology Innovation and Expand Growth, Boosting Market Edge and Launching a Fresh Chapter for the CompanyJINHUA, China, Nov. 18, 2024 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (the “Company”, “we” or “Kandi”) (NASDAQ GS: KNDI), today announced its financial results for the third quarter of 2024. Third Quarter and Nine Months 2024 Financial HighlightsQ3 revenues decreased to $29.9 million, from $36.4 million in the same period of 2023. Nine-month revenues of $89.8 million slipped 5.7% year-over-year. Off-road vehicles and associated parts in Q3 were the primary source of revenue, decreasing by 9.2% y/y to $27.5 million, compared to $30.2 million in the same...

HCW Biologics entered into License, Research and Co-Development Agreement with WY Biotech for one of its new proprietary preclinical molecules HCW Biologics to receive upfront payment of $7 million and is eligible to receive additional milestone payments and double-digit royalties on future product sales MIRAMAR, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) — HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, and WY Biotech Co., Ltd., a China-based company specializing in the early-stage development of recombinant protein drugs and gene/cell therapies, announced today that they have entered into a worldwide exclusive license...

Anthony ArmentaFormer Postmates and GM executive Anthony Armenta will step in as Serve Robotics Chief Software and Data OfficerSAN FRANCISCO, Nov. 18, 2024 (GLOBE NEWSWIRE) — Serve Robotics Inc. (“Serve”) (Nasdaq: SERV), a leading autonomous sidewalk delivery company, today announced the appointment of former Postmates and GM executive Anthony Armenta as Chief Software and Data Officer. In the newly created role, Armenta will lead the development and strengthening of Serve’s software, AI, and autonomy stack, enhancing the robots’ reliability, performance, and ability to scale nation-wide. Armenta re-joins Serve after previously spearheading early development of the company’s autonomous robots as Vice President of Software Engineering at Postmates, prior to Serve’s spin-off from Uber. “We are thrilled...

JUSTIN, Texas and LONDON, Nov. 18, 2024 (GLOBE NEWSWIRE) — Canoo Inc. (Nasdaq: GOEV), a high-tech advanced mobility company, today announced a new service, maintenance, and repair (SMR) agreement with Northside Truck & Van Ltd. (“Northside”), a premier automotive service provider in the United Kingdom. With a current aftersales portfolio of over 280 garages in the country, Northside will provide support and maintenance of Canoo’s light commercial vehicles (LCVs) for commercial fleet and government customers including 24/7/365 maintenance service availability in the United Kingdom. With the growing demand for sustainable commercial transportation solutions, Canoo is at the forefront of providing innovative electric van options customized for customers. By partnering with Northside Truck & Van, Canoo will leverage Northside’s...

Results from 16 new holes show a thick mineralized zone up to 74m with grades up to 4,321 ppm TREO and 1,004 ppm MREO SINGAPORE, Nov. 18, 2024 (GLOBE NEWSWIRE) — Verde AgriTech Ltd (TSX: “NPK“) (OTCQX: “VNPKF“) (“Verde” or the “Company“) is pleased to announce significant drilling results from Alto da Serra target, one of the three targets of the Man of War project. Building on previously announced results from two other targets, Verde has completed the reassaying process with an additional 1,247 meters of results from Alto da Serra. This completes the analysis across the three targets, totaling 3,640 drilling meters. Key results from the latest drilling assays include:13,944 ppm TREO (AP-AD-06 1m @ [38]) and 5,222 ppm MREO (AP-AD-01 1m@ [14]); 4,321 ppm TREO and 1,004 ppm MREO...

The Company will now target five major cancer types with its four clinically active compounds across both TCR-T cell therapies and TCR-based Bispecifics Today, Company discloses first clinical data from the TCR Bispecific molecule, TCER® IMA402 targeting PRAME, in the Phase 1 dose escalation trial, demonstrating a favorable tolerability profile and signs of dose-dependent and PRAME expression-dependent clinical activity, including first objective responses in melanoma patients; early pharmacokinetics data indicate a median half-life of 7 days, potentially enabling bi-weekly dosing; dose escalation is ongoingSUPRAME, the randomized-controlled Phase 3 trial to evaluate ACTengine® IMA203 in 2L+ metastatic melanoma patients, planned to commence in December 2024; pre-specified interim data analysis planned for early 2026Recently, Company...

SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, will participate in the 13th Annual Roth Technology Conference. The conference is being held in New York City on November 19-20, 2024. Cibus is available for meetings on both days of the conference. Conference attendees should reach out to the Company or their conference host representative to schedule. About Cibus Cibus is a leading independent plant trait company that develops and licenses plant traits to seed companies for royalties. Cibus is not a seed company, but rather a technology company that uses its proprietary gene editing technology...

MONTREAL, Nov. 18, 2024 (GLOBE NEWSWIRE) — Goodfood Market Corp. (“Goodfood” or “the Company”) (TSX: FOOD), a leading Canadian online meal solutions company, will release its financial results for the fourth quarter and year end of Fiscal 2024 on Wednesday, November 27, 2024, before markets open. Jonathan Ferrari, CEO, Neil Cuggy, President and COO, and Roslane Aouameur, CFO, will hold a conference call to review the results at 8:00 a.m. (ET) on the same day. Details of the Earnings Conference Call: When: November 27, 2024, at 8:00 a.m. ET Dial in number: 1 (800) 717-1738 or 1 (514) 400-3792 Conference call replay available until December 4, 2024:1 (888) 660-6264Replay passcode: 12890# To access the webcast and view the slide presentation, click on this link:https://www2.makegoodfood.ca/en/investisseurs/evenements  ABOUT GOODFOOD...

— Four Pediatric patients treated in French early-access program achieved meaningful weight reduction at three months on setmelanotide therapy — — Rhythm announced plans for a new substudy to evaluate setmelanotide therapy in patients with congenital hypothalamic obesity — BOSTON, Nov. 18, 2024 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced the presentation of new, real-world data that showed four pediatric patients with acquired hypothalamic obesity or congenital hypothalamic obesity achieved >5% weight reduction at three months on setmelanotide, a melanocortin-4 receptor (MC4R) agonist. These data were among five Rhythm-related presentations...

On 4 March 2024, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 13 of 1 March 2024. Under the programme, Schouw & Co. will acquire shares for up to DKK 200 million during the period 4 March 2024 to 31 December 2024. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount    Accumulated until 8/11/2024 296,787 558.54 165,766,892    Monday, 11 November 2024 1,700 580.89 987,513    Tuesday, 12 November 2024 1,800 583.79 1,050,822    Wednesday, 13 November 2024 1,200 595.12 714,144    Thursday, 14 November 2024 1,400 574.50 804,300    Friday,...